Ex-vivo and in-vivo cell and genetic medicines. * Gene therapy using viral vectors and gene editing. * Autologous and allogenic cell therapy. Role Overview Touchlight is currently seeking a QA ...
Ex-vivo and in-vivo cell and genetic medicines. * Gene therapy using viral vectors and gene editing. * Autologous and allogenic cell therapy. Role Overview Due to the expansion of Touchlight ...
Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic ...
Touchlight has created a new DNA vector for use in advanced genetic medicines that is safer and more efficacious than conventional plasmid DNA. Our unique platform also enables DNA production at ...
All qualified applicants will receive consideration for employment without regard to race, colour, religion, gender, gender identity or expression, sexual orientation, national origin, genetics ...
... genetic information, veteran status, gender identity or expression, sexual or
Our client is a biopharmaceutical company that are committed to rigorous science, driven by the determination to better address treatment needs for patients for rare genetic diseases with ...
We prohibit discrimination and harassment of any kind based on race, colour, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected ...
... genetics, disability, age, or veteran status. Contact Person: Elvis Eckardt
Develop and deliver a comprehensive and engaging biology curriculum that covers essential topics such as cell biology, genetics, ecology, and human biology. • Effective Classroom Instruction
